Fingolimod Mylan Europese Unie - IJslands - EMA (European Medicines Agency)

fingolimod mylan

mylan ireland limited - fingolimod stutt og long-term - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 og 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

GlucaGen Stungulyfsstofn og leysir, lausn 1 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

glucagen stungulyfsstofn og leysir, lausn 1 mg

novo nordisk a/s* - glucagonum hýdróklóríð - stungulyfsstofn og leysir, lausn - 1 mg

Risperdal Consta Stungulyfsstofn og leysir, forðadreifa 50 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

risperdal consta stungulyfsstofn og leysir, forðadreifa 50 mg

janssen-cilag ab - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 50 mg

Risperdal Consta Stungulyfsstofn og leysir, forðadreifa 37,5 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

risperdal consta stungulyfsstofn og leysir, forðadreifa 37,5 mg

janssen-cilag ab - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 37,5 mg

Risperdal Consta Stungulyfsstofn og leysir, forðadreifa 25 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

risperdal consta stungulyfsstofn og leysir, forðadreifa 25 mg

janssen-cilag ab - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 25 mg

Risperidone Teva GmbH Stungulyfsstofn og leysir, forðadreifa 50 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

risperidone teva gmbh stungulyfsstofn og leysir, forðadreifa 50 mg

teva gmbh - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 50 mg

Risperidone Teva GmbH Stungulyfsstofn og leysir, forðadreifa 25 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

risperidone teva gmbh stungulyfsstofn og leysir, forðadreifa 25 mg

teva gmbh - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 25 mg

Risperidone Teva GmbH Stungulyfsstofn og leysir, forðadreifa 37,5 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

risperidone teva gmbh stungulyfsstofn og leysir, forðadreifa 37,5 mg

teva gmbh - risperidonum inn - stungulyfsstofn og leysir, forðadreifa - 37,5 mg

Sandostatin LAR Stungulyfsstofn og leysir, dreifa 10 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

sandostatin lar stungulyfsstofn og leysir, dreifa 10 mg

novartis healthcare a/s - octreotidum inn - stungulyfsstofn og leysir, dreifa - 10 mg

Sandostatin LAR Stungulyfsstofn og leysir, dreifa 20 mg IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

sandostatin lar stungulyfsstofn og leysir, dreifa 20 mg

novartis healthcare a/s - octreotidum inn - stungulyfsstofn og leysir, dreifa - 20 mg